This document provides information about several types of leukemia and related conditions:
1. It describes characteristics of acute lymphoblastic leukemia (ALL) in individuals aged 15-39, including increased lymphoblasts that can spread to the central nervous system and testes, and a better prognosis associated with a 12;21 translocation.
2. It summarizes subtypes of acute myeloid leukemia (AML) in individuals aged 15-60, noting that M2 is the most common subtype and involves Auer rods, and that acute promyelocytic leukemia (M3 subtype) involves a 15;17 translocation and disseminated intravascular coagulation.
3. It provides brief descriptions of
This document provides information about several types of leukemia and related conditions:
1. It describes characteristics of acute lymphoblastic leukemia (ALL) in individuals aged 15-39, including increased lymphoblasts that can spread to the central nervous system and testes, and a better prognosis associated with a 12;21 translocation.
2. It summarizes subtypes of acute myeloid leukemia (AML) in individuals aged 15-60, noting that M2 is the most common subtype and involves Auer rods, and that acute promyelocytic leukemia (M3 subtype) involves a 15;17 translocation and disseminated intravascular coagulation.
3. It provides brief descriptions of
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as XLSX, PDF, TXT or read online from Scribd
This document provides information about several types of leukemia and related conditions:
1. It describes characteristics of acute lymphoblastic leukemia (ALL) in individuals aged 15-39, including increased lymphoblasts that can spread to the central nervous system and testes, and a better prognosis associated with a 12;21 translocation.
2. It summarizes subtypes of acute myeloid leukemia (AML) in individuals aged 15-60, noting that M2 is the most common subtype and involves Auer rods, and that acute promyelocytic leukemia (M3 subtype) involves a 15;17 translocation and disseminated intravascular coagulation.
3. It provides brief descriptions of
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as XLSX, PDF, TXT or read online from Scribd
Increased Lymphoblasts TdT, CALLA, CD10 Spreads to CNS and Testes 12;21 translocation = better prognosis
AML - 15-60 (15-39 = MC; 40-59 = 60%)
M0-M7; M2 is MC Auer Rods in M2 & M3 (Red, Splinter-to-Rod inclusions) Treat M3 w/ Retinoic Acid (Vit A) M3 (Acute Promyelocytic) is d/t 15;17 translocation M3 involves DIC (always present) Thrombocytopenia, Gen Lymph, Hepatosplenomegaly Increased Myeloblasts
Myelofibrosis and Myeloid Metaplasia (MMM)
Mutation in JAK2 gene of Chromosome 9 Ineffective erythropoiesis, Immature granulocytes, Reactive myelofibrosis Extramedullary hematopoiesis in spleen, liver, other Hepatosplenomegally
Hairy Cell Leukemia (middle-aged men)
Uncommon, Chronic B-Cell Leukemia Rarely has Lymphadenopathy Cytoplasmic projections - Stain TRAP + CLL - > 60 yoa MCC of Generalized Nontender Lymphadenopathy MC overall leukemia Smudge cells in peripheral smear Warm antibody AHA (IgG)
CML - 40-60 (40%)
Philadelphia Chromosome (9;22) + bcr-abl fusion Increased Neutrophils and Basophils Blast Crisis (CML to AML or ALL) --> Death in 3-6 mths LOW Leukocyte Alkaline Phosphatase No Auer Rods Thrombocytosis OR Thrombocytopenia
JAK2 Mutations = MMM, Polycythemia vera
Presence of Basophilia = PV, Ess thrombocytosis, MMM, CML